A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples